The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Lymphoma, Low-Grade

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Lymphoma, Low-Grade


High impact information on Lymphoma, Low-Grade


Chemical compound and disease context of Lymphoma, Low-Grade


Biological context of Lymphoma, Low-Grade


Anatomical context of Lymphoma, Low-Grade


Gene context of Lymphoma, Low-Grade


Analytical, diagnostic and therapeutic context of Lymphoma, Low-Grade


  1. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine. Carson, D.A., Wasson, D.B., Esparza, L.M., Carrera, C.J., Kipps, T.J., Cottam, H.B. Proc. Natl. Acad. Sci. U.S.A. (1992) [Pubmed]
  2. An epitope on the transferrin receptor preferentially exposed during tumor progression in human lymphoma is close to the ligand binding site. Takahashi, S., Esserman, L., Levy, R. Blood (1991) [Pubmed]
  3. 2-Chlorodeoxyadenosine activity in patients with untreated, indolent non-Hodgkin's lymphoma. Saven, A., Emanuele, S., Kosty, M., Koziol, J., Ellison, D., Piro, L. Blood (1995) [Pubmed]
  4. The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin. Watanabe, T., Hotta, T., Ichikawa, A., Kinoshita, T., Nagai, H., Uchida, T., Murate, T., Saito, H. Blood (1994) [Pubmed]
  5. Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma. Redman, J.R., Cabanillas, F., Velasquez, W.S., McLaughlin, P., Hagemeister, F.B., Swan, F., Rodriguez, M.A., Plunkett, W.K., Keating, M.J. J. Clin. Oncol. (1992) [Pubmed]
  6. Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma. Habeshaw, J.A., Lister, T.A., Stansfeld, A.G., Greaves, M.F. Lancet (1983) [Pubmed]
  7. Prognostic value of serum beta-2 microglobulin in low-grade lymphoma. Litam, P., Swan, F., Cabanillas, F., Tucker, S.L., McLaughlin, P., Hagemeister, F.B., Rodriguez, M.A., Velasquez, W.S. Ann. Intern. Med. (1991) [Pubmed]
  8. Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group. Lenz, G., Dreyling, M., Schiegnitz, E., Forstpointner, R., Wandt, H., Freund, M., Hess, G., Truemper, L., Diehl, V., Kropff, M., Kneba, M., Schmitz, N., Metzner, B., Pfirrmann, M., Unterhalt, M., Hiddemann, W. Blood (2004) [Pubmed]
  9. Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index. Lim, M.S., Adamson, A., Lin, Z., Perez-Ordonez, B., Jordan, R.C., Tripp, S., Perkins, S.L., Elenitoba-Johnson, K.S. Blood (2002) [Pubmed]
  10. p53 mutation is associated with progression in follicular lymphomas. Sander, C.A., Yano, T., Clark, H.M., Harris, C., Longo, D.L., Jaffe, E.S., Raffeld, M. Blood (1993) [Pubmed]
  11. Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study. Hochster, H.S., Kim, K.M., Green, M.D., Mann, R.B., Neiman, R.S., Oken, M.M., Cassileth, P.A., Stott, P., Ritch, P., O'Connell, M.J. J. Clin. Oncol. (1992) [Pubmed]
  12. Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501. Velasquez, W.S., Lew, D., Grogan, T.M., Spiridonidis, C.H., Balcerzak, S.P., Dakhil, S.R., Miller, T.P., Lanier, K.S., Chapman, R.A., Fisher, R.I. J. Clin. Oncol. (2003) [Pubmed]
  13. Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and and long-term follow-up--a report from the Eastern Cooperative Oncology Group. Hochster, H.S., Oken, M.M., Winter, J.N., Gordon, L.I., Raphael, B.G., Bennett, J.M., Cassileth, P.A. J. Clin. Oncol. (2000) [Pubmed]
  14. Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy. Dana, B.W., Dahlberg, S., Nathwani, B.N., Chase, E., Coltman, C., Miller, T.P., Fisher, R.I. J. Clin. Oncol. (1993) [Pubmed]
  15. Fludarabine versus cyclophosphamide, vincristine, and prednisone in recurrent low-grade lymphomas. Alliot, C. J. Clin. Oncol. (2003) [Pubmed]
  16. Detection of specific t(14;18) chromosomal translocations in fixed tissues. Shibata, D., Hu, E., Weiss, L.M., Brynes, R.K., Nathwani, B.N. Hum. Pathol. (1990) [Pubmed]
  17. PRAD1 gene over-expression in mantle-cell lymphoma but not in other low-grade B-cell lymphomas, including extranodal lymphoma. Oka, K., Ohno, T., Kita, K., Yamaguchi, M., Takakura, N., Nishii, K., Miwa, H., Shirakawa, S. Br. J. Haematol. (1994) [Pubmed]
  18. Lymphocyte immunophenotyping of B-cell lymphomas: a flow cytometric analysis of neoplastic and nonneoplastic cells in 271 cases. de Martini, R.M., Turner, R.R., Boone, D.C., Lukes, R.J., Parker, J.W. Clin. Immunol. Immunopathol. (1988) [Pubmed]
  19. The role of the gallium scan in primary extranodal lymphoma. Hussain, R., Christie, D.R., Gebski, V., Barton, M.B., Gruenewald, S.M. J. Nucl. Med. (1998) [Pubmed]
  20. A quantitative study of histiocytic reticulum cells in diffuse and follicular non-Hodgkin's lymphomas. Crocker, J., Jenkins, R. J. Clin. Pathol. (1984) [Pubmed]
  21. Expression of adhesion molecules in primary B-cell gastric lymphoma and lymphoid follicles. Sato, Y., Ito, M., Morise, K., Saito, Y., Kusugami, K. Virchows Arch. (1996) [Pubmed]
  22. Acute myeloid leukaemia triggering via CD40 induces leukocyte chemoattraction and cytotoxicity against allogenic or autologous leukemic targets. Costello, R.T., Mallet, F., Chambost, H., Sainty, D., Arnoulet, C., Gastaut, J.A., Olive, D. Leukemia (2000) [Pubmed]
  23. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue. Wołowiec, D., Benchaib, M., Pernas, P., Deviller, P., Souchier, C., Rimokh, R., Felman, P., Bryon, P.A., Ffrench, M. Leukemia (1995) [Pubmed]
  24. Immunohistochemical expression of basic fibroblast growth factor, vascular endothelial growth factor, and their receptors in stage IV non-Hodgkin lymphoma. Ho, C.L., Sheu, L.F., Li, C.Y. Appl. Immunohistochem. Mol. Morphol. (2002) [Pubmed]
  25. Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma. Stewart, M., Talks, K., Leek, R., Turley, H., Pezzella, F., Harris, A., Gatter, K. Histopathology (2002) [Pubmed]
  26. Expression of cyclin D1 in mouse B cell lymphomas of different histologic types and differentiation stages. Qi, C.F., Chattopadhyay, S.K., Lander, M., Kim, Y., Fredrickson, T.N., Hartley, J.W., Morse, H.C. Leuk. Res. (1998) [Pubmed]
  27. Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model. Romaguera, J.E., McLaughlin, P., North, L., Dixon, D., Silvermintz, K.B., Garnsey, L.A., Velasquez, W.S., Hagemeister, F.B., Cabanillas, F. J. Clin. Oncol. (1991) [Pubmed]
  28. Proliferation response of leukemic cells to CD70 ligation oscillates with recurrent remission and relapse in a low-grade lymphoma. Kaufmann, Y., Amariglio, N., Rosenthal, E., Hirsch, Y.J., Many, A., Rechavi, G. J. Immunol. (2005) [Pubmed]
  29. Prolonged disease-free survival in relapsed/refractory low-grade lymphoma treated with fludarabine: a report of four cases. Sternberg, A.J., Matutes, E., Killick, S., Wotherspoon, A.C., Catovsky, D. Br. J. Haematol. (1998) [Pubmed]
  30. Intermittent 2-hour-infusion of cladribine as first-line therapy or in first relapse of progressive advanced low-grade and mantle cell lymphomas. Rummel, M.J., Chow, K.U., Jäger, E., Leimer, L., Hossfeld, D.K., Bergmann, L., Peters, H.D., Hansmann, M.L., Meyer, A., Hoelzer, D., Mitrou, P.S. Leuk. Lymphoma (1999) [Pubmed]
  31. Hematopoietic stem cell transplantation in the new millennium: report from City of Hope National Medical Center. Molina, A., Popplewell, L., Kashyap, A., Nademanee, A. Clinical transplants. (2000) [Pubmed]
WikiGenes - Universities